New perspectives on the molecular basis of hereditary bone tumours

Craig McCormick, Gillian Duncan, Frank Tufaro

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

43 Citas (Scopus)

Resumen

Bone development is a highly regulated process sensitive to a wide variety of hormones, inflammatory mediators and growth factors. One of the most common hereditary skeletal dysplasias, hereditary multiple exostoses (HME), is an autosomal dominant disorder characterized by skeletal malformations that manifest as bony, benign tumours near the end of long bones. HME is usually caused by defects in either one of two genes, EXT1 and EXT2, which encode enzymes that catalyze the biosynthesis of heparan sulphate, an important component of the extracellular matrix. Thus, HME- linked bone tumours, like many other skeletal dysplasias, probably result from disruptions in cell surface architecture. However, despite the recent success in unravelling functions for several members of the EXT gene family, significant challenges remain before this knowledge can be used to develop new approaches for the diagnosis and treatment of disease.

Idioma originalEnglish
Páginas (desde-hasta)481-486
Número de páginas6
PublicaciónMolecular Medicine Today
Volumen5
N.º11
DOI
EstadoPublished - nov. 1 1999
Publicado de forma externa

ASJC Scopus Subject Areas

  • Molecular Medicine
  • Genetics

Huella

Profundice en los temas de investigación de 'New perspectives on the molecular basis of hereditary bone tumours'. En conjunto forman una huella única.

Citar esto